NaturoMed Therapeutics, the parent company of Stay Wyld Organics, is a vertically integrated functional and medicinal mushroom company. NaturoMed Therapeutics is currently producing bulk functional mushroom powders at its state of the art facility in BC, Canada and selling functional mushroom products to the retail market throughout North America. The company is committed to improving global mental and physical health through the production and distribution of high-quality Canadian grown organic mushroom products. NaturoMed is excited to announce that construction is well underway for its Health Canada Controlled Substances Dealer’s License to produce Psilocybin. Estimated completion is Q4, 2022. NaturoMed plans to produce Psilocybin once it receives the license. NaturoMed’s lead scientist is currently working on new extraction processes to create medicinal IP.
NaturoMed Therapeutics
Similar Posts
A Big Week for Psychedelic Stocks: 2 CEOs Step Down, MDMA Patents and a Phase 3 Trial
Compass Pathways and Small Pharma announce executive shakeup, Mydecine and Awakn push forward with new research
5 Athletes Who Healed With Psychedelic Therapy
Some of the world’s top athletes have used psychedelic therapy to overcome addiction, depression, and other mental health issues.
Former Director of Psychiatric Products at FDA Joins Psychedelic Life Sciences Company Cybin
Former Food and Drug Administration division director Dr. Thomas Laughren has joined the psychedelic life sciences team at Cybin.
Are We Being Exposed to Psychedelics More Than Ever Before? Survey Says…It’s Complicated
A study of American newspaper mentions of psychedelics doesn’t stack up to what leaders in the industry are observing in the media landscape at large.
Ibogaine Therapy Offers Hope For Opioid Addiction
At his worst, D.F. thought heroin wasn’t his problem. It…
Why Ayahuasca Is Miley Cyrus’ ‘Favorite’ Drug
Singer Miley Cyrus says she’s not likely to do it again, but ayahuasca is one of her favorite experiences. Find out what this psychedelic did for her.